Latest news
Loading news…
Eolo Pharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Wilmington, Delaware, United States Founded 2017 1-10 employees For Profit
Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 31
Company Info
- Founded
- 2017
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 5
- HQ
- Wilmington, Delaware, United States
- Region
- Greater Philadelphia Area, East Coast, Southern US
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -0.4
- Trend (90d)
- -0.7
2
professional contacts at Eolo Pharma
Contact execs at Eolo Pharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Eolo Pharma
Loading news…
FAQs about Eolo Pharma
People who checked this page also checked these
Browse the full Acquirezy directory.